Alpha-fetoprotein-associated alterations of New Zealand mouse immunopathology

M. Eric Gershwin, James J. Castles, Ronald Makishima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The influence(s) of chronic injections of alpha-fetoprotein (AFP), derived from murine amniotic fluid, on the natural history of immunopathology and autoantibody production in New Zealand mice was studied and compared to analagous treatment with albumin, transferrin, or phosphate-buffered saline. Treatment of young New Zealand Black (NZB) mice with AFP, at sera levels of 60-210 μg/ml, significantly reduces the titer of IgG1, IgG2, and IgA antierythrocyte antibodies. Similarly, such treated mice have relatively normal levels of splenic Thy-1.2-bearing cells and sera immunoglobulins, at older ages, compared to control groups. In contrast, AFP has no apparent effect on the appearance of either naturally occurring thymocytotoxic antibodies (NTA) or lymphoma. Moreover, these positive features of AFP on disease were only noted for mice treated early in life; AFP had no effect when injected into older animals. Similar, but not as dramatic, changes were observed in NZB × NZW F1 hybrids. It is concluded that in pharmacologic doses, mouse amniotic fluid enriched with AFP may alter the appearance of thymic-dependent autoantibodies.

Original languageEnglish (US)
Pages (from-to)331-341
Number of pages11
JournalImmunopharmacology
Volume1
Issue number4
DOIs
StatePublished - 1979

Fingerprint

alpha-Fetoproteins
New Zealand
Amniotic Fluid
Autoantibodies
Immunoglobulin G
Antibodies
Transferrin
Natural History
Serum
Immunoglobulin A
Immunoglobulins
Albumins
Lymphoma
Phosphates
Control Groups
Injections
Therapeutics

Keywords

  • Alpha-fetoprotein
  • Autoimmunity
  • New Zealand Mice

ASJC Scopus subject areas

  • Pharmacology

Cite this

Alpha-fetoprotein-associated alterations of New Zealand mouse immunopathology. / Gershwin, M. Eric; Castles, James J.; Makishima, Ronald.

In: Immunopharmacology, Vol. 1, No. 4, 1979, p. 331-341.

Research output: Contribution to journalArticle

Gershwin, M. Eric ; Castles, James J. ; Makishima, Ronald. / Alpha-fetoprotein-associated alterations of New Zealand mouse immunopathology. In: Immunopharmacology. 1979 ; Vol. 1, No. 4. pp. 331-341.
@article{57aa079270de4eb388cc057cf55fed3f,
title = "Alpha-fetoprotein-associated alterations of New Zealand mouse immunopathology",
abstract = "The influence(s) of chronic injections of alpha-fetoprotein (AFP), derived from murine amniotic fluid, on the natural history of immunopathology and autoantibody production in New Zealand mice was studied and compared to analagous treatment with albumin, transferrin, or phosphate-buffered saline. Treatment of young New Zealand Black (NZB) mice with AFP, at sera levels of 60-210 μg/ml, significantly reduces the titer of IgG1, IgG2, and IgA antierythrocyte antibodies. Similarly, such treated mice have relatively normal levels of splenic Thy-1.2-bearing cells and sera immunoglobulins, at older ages, compared to control groups. In contrast, AFP has no apparent effect on the appearance of either naturally occurring thymocytotoxic antibodies (NTA) or lymphoma. Moreover, these positive features of AFP on disease were only noted for mice treated early in life; AFP had no effect when injected into older animals. Similar, but not as dramatic, changes were observed in NZB × NZW F1 hybrids. It is concluded that in pharmacologic doses, mouse amniotic fluid enriched with AFP may alter the appearance of thymic-dependent autoantibodies.",
keywords = "Alpha-fetoprotein, Autoimmunity, New Zealand Mice",
author = "Gershwin, {M. Eric} and Castles, {James J.} and Ronald Makishima",
year = "1979",
doi = "10.1016/0162-3109(79)90030-4",
language = "English (US)",
volume = "1",
pages = "331--341",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Alpha-fetoprotein-associated alterations of New Zealand mouse immunopathology

AU - Gershwin, M. Eric

AU - Castles, James J.

AU - Makishima, Ronald

PY - 1979

Y1 - 1979

N2 - The influence(s) of chronic injections of alpha-fetoprotein (AFP), derived from murine amniotic fluid, on the natural history of immunopathology and autoantibody production in New Zealand mice was studied and compared to analagous treatment with albumin, transferrin, or phosphate-buffered saline. Treatment of young New Zealand Black (NZB) mice with AFP, at sera levels of 60-210 μg/ml, significantly reduces the titer of IgG1, IgG2, and IgA antierythrocyte antibodies. Similarly, such treated mice have relatively normal levels of splenic Thy-1.2-bearing cells and sera immunoglobulins, at older ages, compared to control groups. In contrast, AFP has no apparent effect on the appearance of either naturally occurring thymocytotoxic antibodies (NTA) or lymphoma. Moreover, these positive features of AFP on disease were only noted for mice treated early in life; AFP had no effect when injected into older animals. Similar, but not as dramatic, changes were observed in NZB × NZW F1 hybrids. It is concluded that in pharmacologic doses, mouse amniotic fluid enriched with AFP may alter the appearance of thymic-dependent autoantibodies.

AB - The influence(s) of chronic injections of alpha-fetoprotein (AFP), derived from murine amniotic fluid, on the natural history of immunopathology and autoantibody production in New Zealand mice was studied and compared to analagous treatment with albumin, transferrin, or phosphate-buffered saline. Treatment of young New Zealand Black (NZB) mice with AFP, at sera levels of 60-210 μg/ml, significantly reduces the titer of IgG1, IgG2, and IgA antierythrocyte antibodies. Similarly, such treated mice have relatively normal levels of splenic Thy-1.2-bearing cells and sera immunoglobulins, at older ages, compared to control groups. In contrast, AFP has no apparent effect on the appearance of either naturally occurring thymocytotoxic antibodies (NTA) or lymphoma. Moreover, these positive features of AFP on disease were only noted for mice treated early in life; AFP had no effect when injected into older animals. Similar, but not as dramatic, changes were observed in NZB × NZW F1 hybrids. It is concluded that in pharmacologic doses, mouse amniotic fluid enriched with AFP may alter the appearance of thymic-dependent autoantibodies.

KW - Alpha-fetoprotein

KW - Autoimmunity

KW - New Zealand Mice

UR - http://www.scopus.com/inward/record.url?scp=0018625814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018625814&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(79)90030-4

DO - 10.1016/0162-3109(79)90030-4

M3 - Article

C2 - 95573

AN - SCOPUS:0018625814

VL - 1

SP - 331

EP - 341

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 4

ER -